Sen, E.; Nazlı, M.A.; Maralcan, G.; Ulusoy, B.S.S.; Demircioğlu, M.K.; Söylemez Akkurt, T.; Sökücü, M.; Erdem, G.U.; Yıldırım, M.
Who Are Suitable Patients for Omitting Breast Surgery as an Exceptional Responder in Selected Molecular Subtypes of Breast Cancer After Neoadjuvant Systemic Treatment? Medicina 2025, 61, 48.
https://doi.org/10.3390/medicina61010048
AMA Style
Sen E, Nazlı MA, Maralcan G, Ulusoy BSS, Demircioğlu MK, Söylemez Akkurt T, Sökücü M, Erdem GU, Yıldırım M.
Who Are Suitable Patients for Omitting Breast Surgery as an Exceptional Responder in Selected Molecular Subtypes of Breast Cancer After Neoadjuvant Systemic Treatment? Medicina. 2025; 61(1):48.
https://doi.org/10.3390/medicina61010048
Chicago/Turabian Style
Sen, Ebru, Mehmet Ali Nazlı, Göktürk Maralcan, Bekir Sıtkı Said Ulusoy, Mahmut Kaan Demircioğlu, Tuce Söylemez Akkurt, Mehmet Sökücü, Gökmen Umut Erdem, and Mustafa Yıldırım.
2025. "Who Are Suitable Patients for Omitting Breast Surgery as an Exceptional Responder in Selected Molecular Subtypes of Breast Cancer After Neoadjuvant Systemic Treatment?" Medicina 61, no. 1: 48.
https://doi.org/10.3390/medicina61010048
APA Style
Sen, E., Nazlı, M. A., Maralcan, G., Ulusoy, B. S. S., Demircioğlu, M. K., Söylemez Akkurt, T., Sökücü, M., Erdem, G. U., & Yıldırım, M.
(2025). Who Are Suitable Patients for Omitting Breast Surgery as an Exceptional Responder in Selected Molecular Subtypes of Breast Cancer After Neoadjuvant Systemic Treatment? Medicina, 61(1), 48.
https://doi.org/10.3390/medicina61010048
